Oncolytics Bio322 11th Avenue S.W
Calgary AB T2R 0C5 CAN
Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The primary focus is to advance programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies.
|Andrew R. de Guttadauro||Other Corporate Officer/President, Subsidiary|
|Matthew C. Coffey||CEO/Co-Founder/Director/President|
|Kirk J. Look||CFO|
|Allison Hagerman||Vice President, Divisional|
|Thomas C. Heineman||Chief Medical Officer|